Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients

BACKGROUND: Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease. METHODS: Direct and indirect costs (based on self-reported information on healthcare utilization) and health-related quality of life (HRQL, as assessed by SGRQ, CAT, and EQ-5D-3 L) were compared between...

Descripción completa

Detalles Bibliográficos
Autores principales: Karl, Florian M., Holle, Rolf, Bals, Robert, Greulich, Timm, Jörres, Rudolf A., Karch, Annika, Koch, Armin, Karrasch, Stefan, Leidl, Reiner, Schulz, Holger, Vogelmeier, Claus, Wacker, Margarethe E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392996/
https://www.ncbi.nlm.nih.gov/pubmed/28416015
http://dx.doi.org/10.1186/s12931-017-0543-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392996/
https://www.ncbi.nlm.nih.gov/pubmed/28416015
http://dx.doi.org/10.1186/s12931-017-0543-8

Ejemplares similares